2 Results for "

DLB

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "DLB" in MCE Product Catalog:

Cat. No.: HY-125287
CAS No.: 1802518-63-3
Purity:  99.87%
Synonyms: (Rac)-UCB0599; NPT200-11
Target:  

α-synuclein

Research Areas:  

Neurological Disease

(Rac)-Minzasolmin ((Rac)-UCB0599; NPT200-11) is a blood-brain barrier penetrated alpha-synuclein (ASYN) misfolding inhibitor. (Rac)-Minzasolmin acts on the early stage of ASYN aggregation process, by replacing the membrane-bound oligomers ASYN, allowing them to revert to the monomeric form, while preventing pathological aggregation. (Rac)-Minzasolmin effectively improves the ASYN deposition in the retina and the neuro-pathological indicators in two α-synuclein transgenic mouse models. (Rac)-Minzasolmin can be used for the studies of Parkinson's disease (PD) and dementia with Lewy bodies (DLB) .
loading...
    loading...
Cat. No.: HY-135653A
CAS No.: 1809885-55-9
Purity:  98.25%
Synonyms: (Rac)-BPN-19186
Target:  

Epoxide Hydrolase

Research Areas:  

Neurological Disease

(Rac)-EC5026 ((Rac)-BPN-19186) is a potent piperidine inhibitor of soluble epoxide hydrolase (sEH) extracted from patent WO2019156991A1, page 39, has a Ki of 0.06 nM. (Rac)-EC5026 can be used for the research of Parkinson's disease and dementia with Lewy Bodies (DLB) .
loading...
    loading...